Vera Therapeutics, Inc. (VERA): Price and Financial Metrics

Vera Therapeutics, Inc. (VERA): $45.75

0.15 (-0.33%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add VERA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#287 of 332

in industry

VERA Price/Volume Stats

Current price $45.75 52-week high $51.61
Prev. close $45.90 52-week low $12.28
Day low $44.97 Volume 401,200
Day high $46.46 Avg. volume 907,190
50-day MA $43.03 Dividend yield N/A
200-day MA $40.62 Market Cap 2.90B

VERA Stock Price Chart Interactive Chart >


Vera Therapeutics, Inc. (VERA) Company Bio


Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.


VERA Latest News Stream


Event/Time News Detail
Loading, please wait...

VERA Latest Social Stream


Loading social stream, please wait...

View Full VERA Social Stream

VERA Price Returns

1-mo 12.38%
3-mo 16.41%
6-mo 23.28%
1-year 247.64%
3-year 70.14%
5-year N/A
YTD 197.46%
2023 -20.52%
2022 -27.58%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!